Antineoplastic agents

Country: Estonia
Language: EN ET
Customer: sihtasutus Tartu Ülikooli Kliinikum
Number: 4426497
Publication date: 23-09-2017
Source: TED
Deadline: 2 days
Descripition in original language
Tags: electrotechnical, electronic and electromechanical equipment

Description

  1. Section I
    1. Name and addresses
      sihtasutus Tartu Ülikooli Kliinikum
      Puusepa 1a
      Tartu
      50406
      Estonia
      Telephone: +372 7318152
      E-mail: jane.lepik@kliinikum.ee
      Fax: +372 7319402
    2. Type of the contracting authority:
      Body governed by public law
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Antineoplastiliste ravimite L01XC ostmine.


        Reference number: 185348
      2. Main CPV code:
        33652100, 33652100, 33652100, 33652100, 33652100, 33652100, 33652100, 33652100, 33652100, 33652100
      3. Type of contract:
        Supplies
      4. Short description:

        Käesoleva hanke eesmärk on sõlmida antineoplastiliste ravimite ostmiseks raamleping. Raamleping sõlmitakse iga hanke osa kohta, ühe madalaimat hinda pakkunud pakkujaga, tähtajaga kuni 31.1.2019.


      5. Information about lots:
        This contract is divided into lots: yes
      6. Total value of the procurement:
        Value
    2. Description
      1. Title:

        Rituximab (biooriginaal)


      2. Additional CPV code(s):
        33652100
      3. Place of performance:
      4. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      5. Award criteria:
      6. Information about options:
        Options: no
      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
      9. Title:

        Rituximab


      10. Additional CPV code(s):
        33652100
      11. Place of performance:
      12. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      13. Award criteria:
      14. Information about options:
        Options: no
      15. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      16. Additional information:
      17. Title:

        Rituximab (biooriginaal või biosimilar)


      18. Additional CPV code(s):
        33652100
      19. Place of performance:
      20. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      21. Award criteria:
      22. Information about options:
        Options: no
      23. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      24. Additional information:
      25. Title:

        Trastuzumab


      26. Additional CPV code(s):
        33652100
      27. Place of performance:
      28. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      29. Award criteria:
      30. Information about options:
        Options: no
      31. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      32. Additional information:
      33. Title:

        Trastuzumab


      34. Additional CPV code(s):
        33652100
      35. Place of performance:
      36. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      37. Award criteria:
      38. Information about options:
        Options: no
      39. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      40. Additional information:
      41. Title:

        Pertuzumab


      42. Additional CPV code(s):
        33652100
      43. Place of performance:
      44. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      45. Award criteria:
      46. Information about options:
        Options: no
      47. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      48. Additional information:
      49. Title:

        Pembrolizumabum


      50. Additional CPV code(s):
        33652100
      51. Place of performance:
      52. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      53. Award criteria:
      54. Information about options:
        Options: no
      55. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      56. Additional information:
      57. Title:

        Nivolumab


      58. Additional CPV code(s):
        33652100
      59. Place of performance:
      60. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      61. Award criteria:
      62. Information about options:
        Options: no
      63. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      64. Additional information:
      65. Title:

        Obinutuzumb


      66. Additional CPV code(s):
        33652100
      67. Place of performance:
      68. Description of the procurement:

        Kirjeldus vastavalt Lisale 2.


      69. Award criteria:
      70. Information about options:
        Options: no
      71. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      72. Additional information:
  3. Section IV
  4. Description:
    1. Type of procedure:
      Open procedure
    2. Information about a framework agreement or a dynamic purchasing system:
      The procurement involves the establishment of a framework agreement
    3. Information about electronic auction:
    4. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: yes
  5. Administrative information:
    1. Previous publication concerning this procedure:
      Notice number in the OJ S: 2017/S 071-135742
    2. Information about termination of dynamic purchasing system:
    3. Information about termination of call for competition in the form of a prior information notice:
  1. Lot No: 3
  1. Additional information
  2. Procedures for review
    1. Review body
      Riigihangete vaidlustuskomisjon
      Endla 13/Lõkke 5
      Tallinn
      10122
      Estonia
      Telephone: +372 6113713
      E-mail: vako@fin.ee
      Fax: +372 6113760
    2. Body responsible for mediation procedures
      Riigihangete vaidlustuskomisjon
      Endla 13/Lõkke 5
      Tallinn
      10122
      Estonia
      Telephone: +372 6113713
      E-mail: vako@fin.ee
    3. Service from which information about the review procedure may be obtained
      Riigihangete vaidlustuskomisjon
      Endla 13/Lõkke 5
      Tallinn
      10122
      Estonia
      Telephone: +372 6113713
      E-mail: vako@fin.ee
      Fax: +372 6113760
  3. Date of dispatch of this notice
    2017-09-20

Other tenders from Estonia за for this period

Occupational clothing, special workwear and accessories Source: TED

Sludge disposal services Source: TED

Research services Source: TED

Accommodation, building and window cleaning services Source: TED